Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
International Journal of Chronic Obstructive Pulmonary Disease|March 6, 2014
Efficacy and safety of coadministration of once-daily indacaterol and glycopyrronium versus indacaterol alone in COPD patients: the GLOW6 studyWalter Vincken, Joseph Aumann, Hungta Chen, et al.Journal of Inflammation Research|September 15, 2021
Monomeric CRP is Elevated in Patients with COPD Compared to Non-COPD Control PersonsRevathy Munuswamy, Jana De Brandt, Chris Burtin, et al.Pulmonary Pharmacology & Therapeutics|July 13, 2010
Sustained 24-hour efficacy of once daily indacaterol (300 μg) in patients with chronic obstructive pulmonary disease: a randomized, crossover studyCraig Laforce, Joseph Aumann, Luis de Teresa Parreño, et al.International Journal of Chronic Obstructive Pulmonary Disease|April 22, 2016
The Belgian trial with azithromycin for acute COPD exacerbations requiring hospitalization: an investigator-initiated study protocol for a multicenter, randomized, double-blind, placebo-controlled trialKristina Vermeersch, Maria Gabrovska, Griet Deslypere, et al.Respiratory Research|October 31, 2019
Treatment failure and hospital readmissions in severe COPD exacerbations treated with azithromycin versus placebo - a post-hoc analysis of the BACE randomized controlled trialKristina Vermeersch, Ann Belmans, Kris Bogaerts, et al.American Journal of Respiratory and Critical Care Medicine|May 4, 2019
Azithromycin during Acute Chronic Obstructive Pulmonary Disease Exacerbations Requiring Hospitalization (BACE). A Multicenter, Randomized, Double-Blind, Placebo-controlled TrialKristina Vermeersch, Maria Gabrovska, Joseph Aumann, et al.Pageof 1